Abstract
Purpose: The Wnt pathway is involved in carcinogenesis and three regulatory genes of the Wnt pathway, APC, beta-catenin and Axin are mutated in some primary human cancers. Mutations in these genes can impair the down regulation of beta-catenin, which results in the stabilization of beta-catenin, accumulation of free beta-catenin and subsequent activation of the Wnt pathway. To clarify the genetic alterations of components of the Wnt pathway in oral squamous cell carcinoma (SCC), we examined mutations in the APC, beta-catenin and Axin genes and subcellular localization of beta-catenin. Methods: 20 oral SCC tissues and four cell lines derived from oral SCC were used. Mutational analysis was performed by a single-strand conformation polymorphism (SSCP) method and direct sequecing analysis. The samples were also examined by immunohistochemical staining and immunoblot analysis. Results: In 3 of 4 cell lines, mutations were observed in the APC and Axin1 genes without amino acid substitutions. In a clinical sample, a mutation in the Axin1 gene was detected; a T insertion at codon 250 resulted in the formation of a stop codon at codon 259. In addition, cytoplasmic accumulation of beta-catenin was observed in 3 (75%) of 4 cell lines and 18 (90%) of 20 cancer tissue samples. Conclusion: The Axin1 gene may be one of the mutational target in oral SCC. In addition, the cytoplasmic accumulation of beta-catenin is a common characteristic of oral SCC, but is not closely associated with mutational alterations in the APC, beta-catenin and Axin1 genes.
Similar content being viewed by others
References
Aberle H, Bauer A, Stappert J, Kispert A, Kemler R (1997) Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16(13):3797–3804
Bagutti C, Speight PM, Watt FM (1998) Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 186(1):8–16
Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschdl R, Birchmeier W (1996) Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:638–642
Boynton RF, Blount PL, Yin J, Brown VL, Huang Y, Tong Y, McDaniel T, Newkirk C, Resau JH, Raskind WH, Haggitt RC, Reid BJ, Meltzer SJ (1992) Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers. Proc Natl Acad Sci USA. 15 89(8):3385–3388
Chang KW, Lin SC, Mangold KA, Jean MS, Yuan TC, Lin SN, Chang CS (2000) Alterations of adenomatous polyposis coli (APC) gene in oral squamous cell carcinoma. In J Oral Maxillofac Surg 29:223–226
Chida K, Kato N, Kuroki T (1986) Down regulation of phorbol diester receptors by proteolytic degradation of protein kinase C in a cultured cell line of fetal rat skin keratinocytes. J Biol Chem 261(28):13013–13018
D’Amico D, Carbone DP, Johnson BE, Meltzer SJ, Minutesna JD (1992) Polymorphic sites within the MCC and APC loci reveal very frequent loss of heterozygosity in human small cell lung cancer. Cancer Res 1 52(7):1996–1999
Eagle H (1955) Propagation in a fluid medium of a human epidermoid carcinoma, starain KB. Proc Soc Exp Biol Med 89:485–495
Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA (1996) Laser capture microdissection. Science 274:998–1001
Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hirohashi S (1998) Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res 58:3526–3528
Gottardi CJ, Wong E, Gumbiner BM (2001) E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 28 153(5):1049–1060
Groden J, Thliveris A, Samowiz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Randall B, Hughes JP, Warrington J, Mcpherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M and White R (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589–600
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW (1998) Identification of c-myc as a target of the APC pathway. Science 281:1509–1512
Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y, Nakamura Y (1992a) Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 1 52(23):6696–6698
Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Kato Y, Yanagisawa A, Nakamura Y (1992b) The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 1 52(11):3231–3233
Horikoshi M, Kimura Y, Nagura H, Ono T, Ito H (1974) A new human cell line derived from human carcinoma of the gingiva. I. Its establishment and morphological studies. Jpn J Oral Maxillofac Surg 20(2):100–106
Huang JS, Chiang CP, Kok SH, Kuo YS, Kuo MYP. (1997) Loss of heterozygosity APC and MCC genes in oral squamous cell carcinoma in Taiwan. J Oral Pathol Med 26:322–326
Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y and Miyoshi Y (1998) Activation of the beta-catenin gene by interstitional deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res 58:1021–1026
Jue SF, Bradley RS, Rudnicki JA, Varmus HE, Brown AM (1992) The mouse Wnt-1 gene can act via a paracrine mechanisms in transformation of mammary epithelial cells. Mol Cell Biol 12:321–328
Kemler R (1993) From cadherins to catenins: cytoplasmic protein interaction and regulation of cell adhesion. Trends Genet 9:317–321
Kikuchi A (2000) Regulation of beta-catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 268:243–248
Kondo Y, Kanai Y, Sakamoto M, Genda T, Mizokami M, Ueda R, et al (1999) Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn J Cancer Res 90:1301–1309
Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW, Vogelstein B and Clevers H (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC −/− colon carcinoma. Science 275:1784–1787
de La Coste A, Romangnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95:8847–8851
Largey JS, Meltzer SJ, Sauk JJ, Hebert CA, Archibald DW (1994) Loss of heterozygosity involving the APC gene in oral squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 77(3):260–263
Lo Muzio L, Staibano S, Pannone G, Grieco M, Mignogna MD, Cerrato A, Testa NF and De Rosa C (1999) Beta- and gamma- catenin expression in oral squamous cell carcinomas. Anticancer Res 19:3817–3826
Lo Muzio L, Pannone G, Staibano S, Mignogna M, Grieco M, ramires P, Romito AM, De Rosa G, Piattelli A (2002) WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Anticancer Res 22:565–576
Mann B, Gelos M, Siedow A, Hanski ML, Gratchev A, Ilyas M, Bodmer WF, Moyer MP, Riecken EO, Buhr HJ, Hanski C (1999) Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc Natl Acad Sci USA 96:1603–1608
Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster resion in the APC gene. Hum Mol Genet 1(4):229–233
Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimamoto T and Nakamura Y (1998) Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon3. Cancer Res 58:2524–2527
Momose F, Hirata S, Araida T, Tanaka N, Shioda S (1986) Charactors of three oral squamous cell carcinoma cell lines. J Jpn Stomatol Soc 35:485–495
Moreno-Bueno G, Hardisson D, Sanchez C, Sarrio D, Cassia R, Garcia-Rostan G, Prat J, Guo M, Herman JG, Matias-Guiu X, Esteller M, Palacios J (2002) Abnormalities of the APC/beta-catenin pathway in endometrial cancer. Oncogene 21:7981–7990
Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787–1790
Ninomiya I, Endo Y, Fushida S, Sasagawa T, Miyashita T, Fujimura T, Nishimura G, Tani T, Hashimoto T, Yagi M, Shimizu K, Ohta T, Yonemura Y, Inoue M, Sasaki T, Miwa K (2000) Alteration of beta-catenin expression in esophageal squamous-cell carcinoma. Int J Cancer 15 85(6):757–761
Nollet F, Berx G, Molemans F, Van Roy F (1996)Genomic Organization of the Human beta-catenin Gene (CTNNB1). Genomics 32:413–424
Nylander K, Schildt EB, Eriksson M, Magnusson A, Mehle C, Roos G (1996) A non-random deletion in the p53 gene in oral squamous cell carcinoma. Br J Cancer 73:1381–1386
Omer CA, Miller PJ, Diehl RE, Kral AM (1999) Identification of Tcf4 residues involved in high-affinity beta-catenin binding. Biochem Biophys Res Commun 256:584–590
Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S, Kosma V-M (2001) Reduced expression of a-catenin, b-catenin, and g-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 54:391–395
Rhee C-S, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson DA (2002) Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21(43):6598–6605
Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275:1790–1792
Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishigro H, Fujuta M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y and Nakamura Y (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 24:245–250
Simone NL, Bonner RF, Gillespie JW, Emmert-Buck MR, Liotta LA (1998) Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet 14(7):272–276
Takahashi K, Kanazawa H, Akiyama Y, Tazaki S, Takahara M, Muto T, Tanzawa H and Sato K (1989) Establishment and characterization of a cell line (SAS) from poorly differentiated human squamous cell carcinoma of the tongue. J Jpn Stomatol Soc 38(1):20–28
Taniguchi K, Roberts L, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DN, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W (2002) Mutational spectrum of b-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogenes 21:4863–4871
Tetsu O, McCormick F (1999) beta-catenin regulates expression of cyclinD1 in colon carcinoma cells Nature 398:422–426
Uzawa K, Yoshikawa H, Suzuki H, Tanzawa H, Shimazaki J, Seino S and Sato K (1994) Abnormalities of the adonomatous polyposis coli gene in human oral squamous-cell carcinoma. Int J Cancer 58:814–817
Williams HK, Sanders DSA, Jankowski JAZ, Landini G, Brown AMS (1998) Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 27:308–317
Wong CM, Fan ST, Ng IOL (2001) B-catenin mutation and overexpression in hepatocellular carcinoma. Cancer 92:136–145
Yeh KT, Chang JG, Lin TH, Wang YF, Chang JY, Shih MC, Lin CC (2003) Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer. Int J Oncol 23(4):1001–1007
Yokota N, Nishizawa S, Ohta S, Data H, SugimuraH, Namba H, Maekawa M (2002) Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer 101:198–201
Zecca M, Basler K, Struhl G (1996) Direct and long-range action of a wingless morphogen gradient. Cell 29 87(5):833–844
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Iwai, S., Katagiri, W., Kong, C. et al. Mutations of the APC, beta-catenin, and axin 1 genes and cytoplasmic accumulation of beta-catenin in oral squamous cell carcinoma. J Cancer Res Clin Oncol 131, 773–782 (2005). https://doi.org/10.1007/s00432-005-0027-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-005-0027-y